CD8A and neoplasm: The increased secretion of IFN‐γ by CD8+ T cells within the tumors after combined treatment, as well as the stronger tumor‐killing efficacy demonstrated by the sorted CD8+ T cells from tumors post‐combined treatment, validates this hypothesis.